Agree that it willdefinitely stop the bleeding. But imho, it will take FDA validation to significantly move the needle. That would be btd for cancer(coming), acceptance of HIV BLA (coming), & approval of LH protocol for phase 3 trial(coming).
IMHO, these 3 things will attract some institutional investors that are allowed to venture into OTC. There are more than people realize.
Good news is that there is no longer a "short scenario" 'til approval. Then it will be more about marketing & timing.